Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Not yet recruiting × Myasthenia Gravis × Clear all

Phase

Phase NA 5 Phase EARLY_PHASE1 4 Phase 1 4 Phase 3 2 Phase 2 2 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Recruiting 4 Completed 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 21 Neoplasms 20 Colorectal Neoplasms 19 Pancreatic Neoplasms 14 Multiple Myeloma 14 Recurrence 13 Advanced Solid Tumors 13 Prostatic Neoplasms 12 Stomach Neoplasms 10 Ovarian Neoplasms 10 Leukemia, Myeloid, Acute 10 Advanced Solid Tumor 10 Carcinoma, Hepatocellular 9 Triple Negative Breast Neoplasms 8 Small Cell Lung Carcinoma 7 Melanoma 7 Glioblastoma 7 Lymphoma, B-Cell 6 Head and Neck Neoplasms 6 Uterine Cervical Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Neoplasm Metastasis 5 Lymphoma, Large B-Cell, Diffuse 5 Lung Neoplasms 5 Glioma 5 Endometrial Neoplasms 5 Urinary Bladder Neoplasms 4 Solid Tumors 4 Solid Tumor 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07372807 2026-01-28

RIPERT-MG

Xinqiao Hospital of Chongqing

Phase 1/2 Not yet recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡